- Staat
- MN
- Alter
- 22,0
- Geschlecht
- M
- Eingang
- 16.11.2021
- Impfdatum
- 16.11.2021
- Beginn
- 16.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- SYR / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: ja
Erholt: nein
Cold sweat
Hyperhidrosis
Loss of consciousness
Symptomtext
Patient lost consciousness and was clammy and sweating. Patient was transported to the ER via ambulance.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Loss of consciousness
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- 4,0
- Geschlecht
- M
- Eingang
- 12.04.2022
- Impfdatum
- 01.04.2022
- Beginn
- 04.04.2022
- Tage bis Beginn
- 3,0
- Dosis
- N/A
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: unbekannt
Ecchymosis
Gait disturbance
Induration
Oedema
Pain
Pain in extremity
Tenderness
Symptomtext
4/4/22 (3 days post vaccination) Patient developed induration in right thigh (where Proquad was administered) which was improving. 4/6/22 (5 days post vaccination) developed right thigh pain + overlying ecchymosis + edema. Patient reported pain with walking. 4/10/22 (9 days post-vaccination) Patient seen in office noted to have mild edema & ecchymosis right lateral thigh mildly tender to palpation but mom does report some improvement since onset.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Pain
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- SPEECH/LANGUAGE DELAYS
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 61,0
- Geschlecht
- F
- Eingang
- 09.03.2022
- Impfdatum
- 27.11.2021
- Beginn
- 08.12.2021
- Tage bis Beginn
- 11,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Injection site pain
Pain in extremity
Symptomtext
Patient states arm pain at injection site that has not gone away.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Injection site pain
- Hospital-Tage
- -
- Labordaten
- NA
- Aktuelle Erkrankungen
- NO
- Vorgeschichte
- NO
- Andere Medikamente
- Unknown
- Allergien
- No
- Vorherige Impfungen
- -
- Staat
- IL
- Alter
- 50,0
- Geschlecht
- F
- Eingang
- 21.11.2021
- Impfdatum
- 18.11.2021
- Beginn
- 18.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Body temperature increased
Chills
Headache
Malaise
Pain in extremity
Symptomtext
My arms became sore in the evening. Around 3:00 am the next morning, I started to become chilled, headache, not well. I took my oral temp, it read 100.5. I took Tylenol. I was not able to rest comfortably. I had similar symptoms after the second dose. The only thing different was that my temp was higher, I believe it was a little over 101. I continued to take Tylenol for the remainder of the day. I felt much better the next day, Saturday. My arms, both, are still a little sore, but not raging like the evening I received both injections.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Chills
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- None
- Vorgeschichte
- No
- Andere Medikamente
- None
- Allergien
- None
- Vorherige Impfungen
- I received the second dose of Moderna, Feb. 19, 2021, the next day (2/20/21) I had a fever over 101, lethargic, painful injecti
- Staat
- SD
- Alter
- 7,0
- Geschlecht
- F
- Eingang
- 06.11.2021
- Impfdatum
- 06.11.2021
- Beginn
- 06.11.2021
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Fall
Head injury
Headache
Symptomtext
I gave patient a Flu shot, she got up and went to stand by her dad outside of the booth. I gave mom her vaccinations. Then mom went out to stand with the little girl. Then I started to give dad his vaccination when I noticed that the daughter had fallen down. This was probably 5 minutes after vaccination. I went out immediately to check on her and she was just opening her eyes and said she didn't know what happened. She asked for a drink of water and so I gave her a drink of water and called for assistance from store management. She said her head hurt (I think she hit it when she fell) and I asked if she would like an ice pack, she said yes, so I gave her an ice pack and she sat for probably another 15 - 20 minutes and then she said she was feeling better and so they left. Store management also collected information from mom and dad for their report.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Headache
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- unknown vaccination, patient got dizzy and flushed following her school shots.
- Staat
- IN
- Alter
- 0,8
- Geschlecht
- F
- Eingang
- 17.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product storage error
Symptomtext
medication error due to vaccines being given post temperature excursion with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 9 months old female patient who experienced medication error due to vaccines being given post temperature excursion with no reported adverse event while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-May-2022, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT7376NA(expiry date: 30-Jun-2022) via intramuscular route in the left thigh for Immunization. On 03-MAY-2022 the patient developed a non-serious medication error due to vaccines being given post temperature excursion with no reported adverse event (medication error) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. It was not reported if the patient received a corrective treatment for the event (medication error due to vaccines being given post temperature excursion with no reported adverse event). At time of reporting, the outcome was Unknown for the event medication error due to vaccines being given post temperature excursion with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 11,0
- Geschlecht
- M
- Eingang
- 17.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
vaccines being given post temperature excursion, with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from a healthcare professional via Physician. This case involves a 11 years old male patient for whom vaccines being given post temperature excursion, with no reported adverse event while receiving Influenza Quadrival A-B Vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included HPV Vaccine (HPV Vaccine) for Immunisation. On 02-May-2022, the patient received a dose of 0.5 ml TOTAL of suspect Influenza Quadrival A-B Vaccine (lot UT7376NA; expiry date 30-Jun-2022) via intramuscular route in the right deltoid for Immunization. On 02-MAY-2022 the patient reported vaccines being given post temperature excursion, with no reported adverse event (product storage error) following the administration of Influenza Quadrival A-B Vaccine. Action taken with Quadrivalent Influenza Vaccine (Fluzone QIV) was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01090544: 01092803: 01092787: 01092741: 2022SA167374:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- HPV VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 3,0
- Geschlecht
- F
- Eingang
- 14.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / RA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
vaccines being given post temperature excursion with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 3 years old female patient whom influenza quadrival A-B vaccine [Fluzone QIV] was given post temperature excursion with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-May-2022, the patient received 0.5 ml dose of suspect influenza quadrival A-B vaccine, suspension for injection (lot UT7376NA expiry date : 30-Jun-2022) via intramuscular route in the right deltoid for prophylactic vaccination was given post temperature excursion with no reported adverse event (intercepted product storage error). Action taken : not applicable. At time of reporting, the outcome was Unknown for the event vaccines being given post temperature excursion with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01092869: 01092879: 01092814: 01092832: 01092891: 01092687: 01092746: 01092709: 01092741: 01092787: 01092850:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 1,9
- Geschlecht
- F
- Eingang
- 14.05.2022
- Impfdatum
- 03.05.2022
- Beginn
- 03.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Medication error
No adverse event
Product storage error
Symptomtext
vaccines being given post temperature excursion (with no reported adverse event); Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 23 months old female patient who experienced vaccines being given post temperature excursion (with no reported adverse event) while receiving vaccine INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included DIPHTHERIA VACCINE TOXOID, PERTUSSIS VACCINE ACELLULAR, TETANUS VACCINE TOXOID (DAPTACEL); HEPATITIS A VACCINE (HEPATITIS A); and PNEUMOCOCCAL VACCINE CONJ 7V (CRM197) (PREVNAR). On 03-May-2022, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE lot UT7376NA(expiry date:30-Jun-2022) via intramuscular route in the left thigh for Immunization. On 03-MAY-2022 (latency: Same day) the patient developed a non-serious vaccines being given post temperature excursion (with no reported adverse event) (product storage error) following the administration of INFLUENZA QUADRIVAL A-B VACCINE. Action taken with QUADRIVALENT INFLUENZA VACCINE (FLUZONE QIV) was not applicable. It was not reported if the patient received a corrective treatment for the event (vaccines being given post temperature excursion (with no reported adverse event)). At time of reporting, the outcome was Not Recovered / Not Resolved for the event vaccines being given post temperature excursion (with no reported adverse event). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Medication error
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- DAPTACEL; HEPATITIS A; PREVNAR
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- IN
- Alter
- 7,0
- Geschlecht
- M
- Eingang
- 14.05.2022
- Impfdatum
- 02.05.2022
- Beginn
- 02.05.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
No adverse event
Product storage error
Symptomtext
vaccines being given post temperature excursion with no reported adverse event; Initial information received on 06-May-2022 regarding an unsolicited valid non-serious case received via other health professional. This case involves a 7 years old male patient who experienced vaccines being given post temperature excursion with no reported adverse event while receiving vaccine influenza quadrival a-b vaccine [Fluzone QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Covid-19 Vaccine for Prophylactic vaccination. On 02-May-2022, the patient received a dose of suspect influenza quadrival a-b vaccine at a dose of 0.5 ml with lot UT7376NA via intramuscular route in the left deltoid for Immunization. On 02-May-2022 (latency: same day) the patient developed vaccines being given post temperature excursion with no reported adverse event (poor quality product administered) following the administration of influenza quadrival a-b vaccine. Action taken: not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments: 01092869: 01092879: 01092814: 01092832: 01092891: 01092687: 01092746: 01092709: 01092787: 01092803: 01092850:
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- No adverse event
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- COVID-19 VACCINE
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- NY
- Alter
- 1,5
- Geschlecht
- F
- Eingang
- 28.03.2022
- Impfdatum
- 22.03.2022
- Beginn
- 22.03.2022
- Tage bis Beginn
- 0,0
- Dosis
- UNK
- Route/Site
- OT / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
patient inadvertently received an extra (third) dose of FLUZONE with no reported adverse event; Initial information received on 22-Mar-2022 regarding an unsolicited valid non-serious case received from an other health professional. This case involves an 18 months old female patient who inadvertently received an extra (third) dose of Influenza quadrival A-B vaccine [Fluzone Quadrivalent] with no reported adverse event. The patient's past vaccination(s) included Fluzone Quadrivalent on 30-NOV-2021 and 03-FEB-2022. The patient's past medical history, medical treatment(s) and family history were not provided. Concomitant medications included hepatitis B vaccine RHBSAG (yeast) (Recombivax) for Prophylactic vaccination. On 22-Mar-2022, the patient received a dose of suspect Influenza quadrival A-B vaccine (with an unknown formulation and strength) (lot number: UT7376NA and expiry date: 30-Jun-2022) at a dosage of 0.5 mL via intramuscular route in the left arm for prophylactic immunization. On 22-MAR-2022 (latency: same day) the patient inadvertently received an extra (third) dose of Influenza quadrival A-B vaccine with no reported adverse event (extra dose administered). Action taken was not applicable. Outcome: Unknown This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- -
- Alter
- -
- Geschlecht
- U
- Eingang
- 12.02.2022
- Impfdatum
- -
- Beginn
- -
- Tage bis Beginn
- -
- Dosis
- UNK
- Route/Site
- OT / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Product administered to patient of inappropriate age
Symptomtext
2nd dose of fluzone high dose quadrivalent was administered 11 days after the first dose was given with no reported adverse event; Initial information received on 01-Feb-2022 regarding an unsolicited valid non-serious case received from an other health professional. This case involves a 6 month old and unknown gender patient to whom 2nd dose of influenza quadrival a-b high dose hv vaccine [Fluzone high-dose quadrivalent] was administered 11 days after the first dose was given with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received the first dose of suspect influenza quadrival a-b high dose hv vaccine once (lot number and expiry date: unknown) via unknown route in unknown administration site as prophylactic vaccination. On an unknown date the patient received the second dose of the same vaccine once (lot: UT7376NA and expiry date: 30-Jun-2022) unk via unknown route in unknown administration site as prophylactic vaccination. It was reported that the second dose of fluzone high dose quadrivalent was administered 11 days after the first dose was given (Inappropriate schedule of product administration, latency: unknown). The reporter enquired if there would be any harm to the baby as well as was asking for a suggestion if they needed to give another dose. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (2nd dose of fluzone high dose quadrivalent was administered 11 days after the first dose was given with no reported adverse event). At time of reporting, the outcome was Unknown for the event 2nd dose of fluzone high dose quadrivalent was administered 11 days after the first dose was given with no reported adverse event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- -
- Vorgeschichte
- -
- Andere Medikamente
- -
- Allergien
- -
- Vorherige Impfungen
- -
- Staat
- MA
- Alter
- 1,3
- Geschlecht
- F
- Eingang
- 10.02.2022
- Impfdatum
- 09.02.2022
- Beginn
- 09.02.2022
- Tage bis Beginn
- 0,0
- Dosis
- 3
- Route/Site
- IM / LL
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Extra dose administered
Symptomtext
3rd dose given in error.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- none
- Aktuelle Erkrankungen
- recurrent acute suppurative otitis media without spontaneous rupture
- Vorgeschichte
- none
- Andere Medikamente
- Pediatric multivitamins/Fluoride
- Allergien
- NKA
- Vorherige Impfungen
- -
- Staat
- ME
- Alter
- 13,0
- Geschlecht
- F
- Eingang
- 02.02.2022
- Impfdatum
- 25.01.2022
- Beginn
- 25.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / -
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: nein
Extra dose administered
No adverse event
Symptomtext
Patient was given a 2nd dose of Influenza vaccine on 1/25/22. Patient had already received this season's influenza vaccine on 9/17/21. No adverse symptoms reported at time of vaccination or to current date.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Extra dose administered
- Hospital-Tage
- -
- Labordaten
- -
- Aktuelle Erkrankungen
- Knee pain, heavy menses, abdominal pain/nausea
- Vorgeschichte
- ADHD, adjustment disorder
- Andere Medikamente
- Loestrin FE tablet daily
- Allergien
- None known
- Vorherige Impfungen
- -
- Staat
- TX
- Alter
- 16,0
- Geschlecht
- F
- Eingang
- 02.01.2022
- Impfdatum
- 01.01.2022
- Beginn
- 01.01.2022
- Tage bis Beginn
- 0,0
- Dosis
- 1
- Route/Site
- IM / LA
Tod: unbekannt
Lebensbedrohlich: unbekannt
Hospital: unbekannt
Disable: unbekannt
ER: unbekannt
Erholt: ja
Interchange of vaccine products
Symptomtext
Patient was administered covid Pfizer vaccine on 1/1/22. Patient was already vaccinated with 2 moderna's elsewhere. Patient was seen by provider and is monitored by nurse for 24 hours. Patient denied any adverse signs or symptoms.
Weitere VAERSDATA-Felder
- Praegender Schweregrund
- Interchange of vaccine products
- Hospital-Tage
- -
- Labordaten
- n/a
- Aktuelle Erkrankungen
- n/a
- Vorgeschichte
- n/a
- Andere Medikamente
- n/a
- Allergien
- Lactose Intolerant
- Vorherige Impfungen
- -